Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis-driven nanotherapeutics for cancer treatment
Xinzhu Shan, Shumeng Li, Bingjun Sun, et al.
Journal of Controlled Release (2020) Vol. 319, pp. 322-332
Closed Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Oxidative Damage and Antioxidant Defense in Ferroptosis
Feimei Kuang, Jiao Liu, Daolin Tang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 389
Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis
Hongdong Ma, Xindong Wang, Weilin Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 318
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Bin Ji, Minjie Wei, Bin Yang
Theranostics (2021) Vol. 12, Iss. 1, pp. 434-458
Open Access | Times Cited: 315
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Yi Liu, Yicong Wan, Yi Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188890-188890
Closed Access | Times Cited: 195
Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication
Xuliang Guo, Fang Liu, Jian Deng, et al.
ACS Nano (2020) Vol. 14, Iss. 11, pp. 14715-14730
Closed Access | Times Cited: 161
Ferroptosis in Cancer Treatment: Another Way to Rome
Yinan Wu, Chengcheng Yu, Meng Luo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 147
Bioengineered nanogels for cancer immunotherapy
Xianbin Ma, Shu‐Jin Li, Yuantong Liu, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5136-5174
Closed Access | Times Cited: 126
Engineered nanomaterials for synergistic photo-immunotherapy
Ranran Guo, Siqi Wang, Lin Zhao, et al.
Biomaterials (2022) Vol. 282, pp. 121425-121425
Closed Access | Times Cited: 106
Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 84
Biomimetic platelet membrane-coated nanoparticles for targeted therapy
Huijie Han, Raquel Bártolo, Jiachen Li, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 172, pp. 1-15
Open Access | Times Cited: 79
Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy
Ping Huang, Yao Yang, Wenyan Wang, et al.
Biomaterials (2023) Vol. 299, pp. 122157-122157
Closed Access | Times Cited: 58
Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging
Min Jun Ko, Sunhong Min, Hyunsik Hong, et al.
Bioactive Materials (2023) Vol. 32, pp. 66-97
Open Access | Times Cited: 46
Emerging nitric oxide gas‐assisted cancer photothermal treatment
Shuang Liang, Yufei Liu, Hongquan Zhu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 37
Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 4
Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia
Tianshu Wu, Liang Xue, Xi Liu, et al.
Particle and Fibre Toxicology (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 108
Dimeric prodrug-based nanomedicines for cancer therapy
Shumeng Li, Xinzhu Shan, Yuequan Wang, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 510-522
Closed Access | Times Cited: 97
Recent progress on targeting ferroptosis for cancer therapy
Guangxiang Xu, Han Wang, Xiaoling Li, et al.
Biochemical Pharmacology (2021) Vol. 190, pp. 114584-114584
Closed Access | Times Cited: 93
Smart transformable nanomedicines for cancer therapy
Yuequan Wang, Shumeng Li, Xinhui Wang, et al.
Biomaterials (2021) Vol. 271, pp. 120737-120737
Closed Access | Times Cited: 91
Gene interfered-ferroptosis therapy for cancers
Jinliang Gao, Tao Luo, Jinke Wang
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy
Liang Yu, Li Zhang, Chao Peng, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3231-3243
Open Access | Times Cited: 79
Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy
Xianchuang Liu, Xinyang Zhu, Xun Qi, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 1037-1050
Open Access | Times Cited: 78
Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer
Xinghan Wu, Chuanliang Liu, Zihaoran Li, et al.
Molecular and Cellular Biochemistry (2020) Vol. 473, Iss. 1-2, pp. 217-228
Closed Access | Times Cited: 73
Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.
Ye Zeng, Qiangsheng Hu, Qifeng Zhuo, et al.
PubMed (2020) Vol. 10, Iss. 4, pp. 1182-1193
Closed Access | Times Cited: 72
Metal-phenolic networks for cancer theranostics
Peng Liu, Xinyi Shi, Shenghui Zhong, et al.
Biomaterials Science (2021) Vol. 9, Iss. 8, pp. 2825-2849
Closed Access | Times Cited: 68
Emerging nanomedicines of paclitaxel for cancer treatment
Qin Chen, Shu Xu, Shuo Liu, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 280-294
Closed Access | Times Cited: 63
Page 1 - Next Page

Scroll to top